Pages that link to "Q79177389"
Jump to navigation
Jump to search
The following pages link to Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin (Q79177389):
Displaying 50 items.
- Individualizing therapy - in search of approaches to maximize the benefit of drug treatment (II) (Q24804024) (← links)
- Metabolism of diphenylhydantoin (phenytoin) during pregnancy (Q28325804) (← links)
- Choreo-athetosis and encephalopathy induced by phenytoin (Q28362813) (← links)
- Identification and prevention of antiepileptic drug noncompliance: the collaborative use of state-supplied pharmaceutical data (Q30791838) (← links)
- "Therapeutic" serum concentration of phenytoin: the influence of seizure type (Q33619501) (← links)
- Overview of systematic reviews of therapeutic ranges: methodologies and recommendations for practice. (Q33755883) (← links)
- Is there a role for therapeutic drug monitoring of new anticonvulsants? (Q33882616) (← links)
- Inhibition of glucagon secretion by diphenylhydantoin in a patient with glucagonoma (Q34108250) (← links)
- Serum phenytoin concentration and clinical response in patients with epilepsy (Q34449582) (← links)
- Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients (Q34451379) (← links)
- Compliance with anticonvulsant therapy in a hospital clinic and in the community (Q34516698) (← links)
- Individual variation in daily dosage requirements for phenytoin sodium in patients with epilepsy (Q34516924) (← links)
- Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy (Q34745264) (← links)
- Pharmacokinetic observations of phenytoin disposition in the newborn and young infant (Q34985675) (← links)
- Drug estimation in the treatment of epilepsy (Q35145404) (← links)
- Electroencephalography and phenytoin toxicity in mentally retarded epileptic patients (Q37058445) (← links)
- The distribution of plasma phenytoin levels in epileptic patients (Q37070680) (← links)
- Phenytoin intoxication induced by sulthiame in epileptic patients (Q37097628) (← links)
- Neuro-ophthalmological signs during rapid intravenous administration of phenytoin. (Q37221046) (← links)
- An updated comparison of drug dosing methods. Part I: Phenytoin (Q37332723) (← links)
- Therapeutic drug monitoring of anticonvulsants. State of the art. (Q37913134) (← links)
- Therapeutic drug monitoring of phenytoin. Rationale and current status (Q38018025) (← links)
- Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach. (Q38840677) (← links)
- Drug level monitoring in paediatric practice (Q38914642) (← links)
- Comparative evaluation of six techniques for determining the Michaelis-Menten parameters relating phenytoin dose and steady-state serum concentrations (Q39234330) (← links)
- One drug (phenytoin) in the treatment of epilepsy (Q39376925) (← links)
- Salivary phenytoin concentrations in epilepsy and in chronic renal failure (Q39467922) (← links)
- Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy (Q39467929) (← links)
- Drug treatment of epilepsy (Q39507539) (← links)
- Individual Differences in the Disposition of Drugs Metabolised in the Body (Q39720658) (← links)
- Clinical Pharmacokinetics of Phenytoin (Q39806205) (← links)
- Comparison of drug dosing methods (Q39814629) (← links)
- Pharmacology of Anticonvulsants (Q39917177) (← links)
- Measurement of Therapeutic Agents in Blood (Q39935532) (← links)
- The role of the liver in drug metabolism (Q39998638) (← links)
- Clinical relevance of pharmacokinetics (Q40081906) (← links)
- Reassessment of the concept of a therapeutic range of anticonvulsant plasma levels (Q40160330) (← links)
- Antiepileptic therapeutic drug monitoring. (Q40265358) (← links)
- The Role of Therapeutic Drug Monitoring in Improving the Cost Effectiveness of Anticonvulsant Therapy (Q40430957) (← links)
- Management of seizure disorders: selected aspects. Part I (Q40588083) (← links)
- Newer antiepileptic drugs. Towards an improved risk-benefit ratio (Q40626178) (← links)
- Correlation of the e.m.i.t. diphenylhydantoin assay in blood plasma with a g.l.c. and a spectrophotometric method (Q40795182) (← links)
- Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes? (Q40860727) (← links)
- Carbamazepine and the Electroencephalogram of Epileptics: A Double Blind Study in Comparison to Phenytoin (Q40920940) (← links)
- Sodium Valproate, Serum Level and Clinical Effect in Epilepsy: A Controlled Study (Q41047875) (← links)
- Drugs and brain death (Q41230903) (← links)
- Target concentration strategy for cyclosporin monitoring (Q41401735) (← links)
- The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy (Q41887334) (← links)
- Control of long-term therapy with diphenylhydantoin. Gas-chromatographic determination of diphenylhydantoin and hydroxy-diphenylhydantoin (Q42230509) (← links)
- The neurologic hazards ofdiphenylhydantoin in childhood (Q42239519) (← links)